These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1705425

  • 1. Anti-platelet activating factor, anti-leukotriene D4 and some other antiallergic activities of mequitazine.
    Tasaka K, Akagi M, Mio M, Izushi K, Aoki I.
    Arzneimittelforschung; 1990 Oct; 40(10):1092-7. PubMed ID: 1705425
    [Abstract] [Full Text] [Related]

  • 2. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K, Akagi M, Izushi K, Mio M.
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [Abstract] [Full Text] [Related]

  • 3. Effect of loratadine on immediate and delayed type hypersensitivity reactions.
    Tasaka K, Kamei C, Akagi M, Mio M, Izushi K, Yoshida T, Nakamura S.
    Arzneimittelforschung; 1995 Jul; 45(7):796-804. PubMed ID: 8573225
    [Abstract] [Full Text] [Related]

  • 4. [Antiallergic effects of mequitazine. 1. In vitro experiments].
    Kohno S, Yamamura H, Ohata K, Nagai H, Koda A, Yanagihara Y, Shida T, Masuki S, Yoshida Y, Tatumi H.
    Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):145-57. PubMed ID: 2465260
    [Abstract] [Full Text] [Related]

  • 5. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K, Kamei C, Akagi M, Mio M, Shirasaka T, Chokki M.
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [Abstract] [Full Text] [Related]

  • 6. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of MY-1250 on histamine release from rat peritoneal mast cells and guinea pig lung fragments: the elucidation of the mechanism.
    Kamei C, Mio M, Izushi K, Yoshii N, Fujisawa K, Tasaka K.
    Immunopharmacol Immunotoxicol; 1991 May; 13(3):341-56. PubMed ID: 1719061
    [Abstract] [Full Text] [Related]

  • 8. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
    Kamei C, Mio M, Kitazumi K, Tsujimoto S, Yoshida T, Adachi Y, Tasaka K.
    Immunopharmacol Immunotoxicol; 1992 May; 14(1-2):207-18. PubMed ID: 1350791
    [Abstract] [Full Text] [Related]

  • 9. Leukotriene D4 and platelet-activating factor-acether antagonists on allergic and arachidonic acid-induced reactions in guinea pig airways.
    Burka JF, Briand H, Scott-Savage P, Pasutto FM.
    Can J Physiol Pharmacol; 1989 May; 67(5):483-90. PubMed ID: 2504467
    [Abstract] [Full Text] [Related]

  • 10. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 11. Antiallergic effects of terfenadine on immediate type hypersensitivity reactions.
    Akagi M, Mio M, Miyoshi K, Tasaka K.
    Immunopharmacol Immunotoxicol; 1987 Jan; 9(2-3):257-79. PubMed ID: 2449487
    [Abstract] [Full Text] [Related]

  • 12. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y, Abe T, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [Abstract] [Full Text] [Related]

  • 13. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A, Nagai H, Mori H, Inagaki N, Nishiyori T, Matsuura N, Iwamoto T, Furukawa K, Yamada H, Goto S.
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [Abstract] [Full Text] [Related]

  • 14. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T, Saito T, Tajima S, Shimohara K, Ito K.
    Arzneimittelforschung; 1984 Nov; 34(7):805-10. PubMed ID: 6208915
    [Abstract] [Full Text] [Related]

  • 15. Effects of antiallergic drugs on histamine release from rat peritoneal mast cells induced by bradykinin.
    Sugimoto Y, Tarumi T, Zhao QE, Fujii Y, Kamei C.
    Methods Find Exp Clin Pharmacol; 1998 Nov; 20(6):457-62. PubMed ID: 9789869
    [Abstract] [Full Text] [Related]

  • 16. Immunopharmacological studies on TBX, a new antiallergic drug (3). Inhibitory effects on histamine release from lung fragments and bronchoconstriction in guinea pigs.
    Yanagihara Y, Kasai H, Matsui S, Ninomiya K.
    Jpn J Pharmacol; 1989 Sep; 51(1):83-92. PubMed ID: 2478743
    [Abstract] [Full Text] [Related]

  • 17. Platelet-activating factor (PAF) and PAF antagonists in asthma.
    Hosford D, Mencia-Huerta JM, Braquet P.
    Crit Rev Ther Drug Carrier Syst; 1990 Sep; 7(3):261-73. PubMed ID: 2073689
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Tomioka K, Yamada T, Mase T, Hara H, Murase K.
    Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
    [Abstract] [Full Text] [Related]

  • 19. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 3rd communication: inhibitory effects on histamine release from lung fragments, Schultz-Dale reaction in isolated tracheal muscle and experimental asthma in guinea pigs.
    Yanagihara Y, Abe T, Kuroda T, Shida T.
    Arzneimittelforschung; 1988 Jan; 38(1):80-3. PubMed ID: 2452640
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
    Yamada N, Yamada K, Takahashi K, Nakao E, Kadowaki S, Umezu K.
    Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.